Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?

Loading...

Date

2018-09

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

113
views
189
downloads

Citation Stats

Attention Stats

Abstract

There are >1.4 million adult congenital heart disease (CHD; ACHD) patients living in the United States. Coronary artery disease (CAD) is at least as prevalent in ACHD patients as in the general population and has become a leading cause of their mortality. In the majority of cases, CAD in the ACHD population is driven by the presence of traditional cardiovascular disease (CVD) risk factors. 80% of ACHD patients have at least one CVD risk factor. Hypertension (HTN), obesity and physical inactivity are frequently seen in both pediatric and adult patients with CHD. Many ACHD patients demonstrate abnormal glucose metabolism and are at an increased risk for developing diabetes. Current guidelines for CVD risk assessment and prevention do not specifically mention patients with CHD but are likely applicable to most of these patients. Specific CHD populations have "high-risk" lesions that are associated with an increased risk of CVD complications and may warrant intensified screening and treatment. These include patients with a history of coarctation of the aorta or with prior coronary artery ostial manipulation (patients with a history of d-transposition of the great arteries or anomalous aortic origin of a coronary artery). The physiology of single ventricle patients is also poorly suited for the effects of superimposed CVD; these patients may benefit from intensified treatment of CVD risk factors, particularly HTN and obesity.

Department

Description

Provenance

Subjects

Humans, Cardiovascular Diseases, Heart Defects, Congenital, Prevalence, Risk Assessment, Risk Factors, Adult, Survivors, Preventive Health Services, Practice Guidelines as Topic

Citation

Published Version (Please cite this version)

10.1016/j.pcad.2018.07.018

Publication Info

Awerbach, Jordan D, Richard A Krasuski and Michael GW Camitta (2018). Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?. Progress in cardiovascular diseases, 61(3-4). pp. 300–307. 10.1016/j.pcad.2018.07.018 Retrieved from https://hdl.handle.net/10161/17942.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Endorsement

Review

Supplemented By

Referenced By

Scholars@Duke

Krasuski

Richard Andrew Krasuski

Adjunct Professor in the Department of Medicine

Dr. Richard Krasuski is an Adjunct Professor of Medicine and Pediatrics at Duke University Medical Center. He was formerly the Director of the Adult Congenital Heart Center, Director of Hemodynamic Research, and the Medical Director of the CTEPH Program at Duke. He is considered a thought leader in the fields of pulmonary hypertension and congenital heart disease. His research focus is in epidemiologic and clinical studies involving patients with pulmonary hypertension and patients with congenital heart disease. He is involved in multiple multicenter studies through the Alliance for Adult Research in Congenital Cardiology (AARCC). He has also helped to develop multiple research databases in these patient populations. He is Co-PI in the EPIPHANY Study examining the impact of medical and transcatheter interventions on RV-PA coupling in patients with chronic thromboembolic pulmonary hypertension. Over his career he has mentored over 100 students, residents and fellows and has published over 350 peer reviewed articles, book chapters and meeting abstracts. He is also the Chief Editor of Advances in Pulmonary Hypertension and on the editorial boards of >20 leading medical journals. He has been an invited speaker at over 100 medical centers worldwide.

Camitta

Michael G.W. Camitta

Professor of Pediatrics

Echocardiography

Fetal cardiology

Pediatric congenital and acquired heart disease

Adult congenital heart disease

Single ventricle palliation approaches, long-term medical therapies and outcome improvement.

Pericardial effusions after bone marrow transplantation.

Risk factors for development of pulmonary hypertension in the adult congenital cardiac population

Treatment of pulmonary hypertension in adult congenital cardiac patients


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.